1. Home
  2. FIVE vs RDY Comparison

FIVE vs RDY Comparison

Compare FIVE & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Below Inc.

FIVE

Five Below Inc.

HOLD

Current Price

$212.19

Market Cap

12.1B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.85

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVE
RDY
Founded
2002
1984
Country
United States
India
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
11.6B
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
FIVE
RDY
Price
$212.19
$13.85
Analyst Decision
Buy
Strong Buy
Analyst Count
19
1
Target Price
$190.89
$16.90
AVG Volume (30 Days)
829.6K
1.8M
Earning Date
03-18-2026
05-08-2026
Dividend Yield
N/A
0.52%
EPS Growth
N/A
N/A
EPS
2.17
N/A
Revenue
$3,876,527,000.00
N/A
Revenue This Year
$24.54
$7.50
Revenue Next Year
$10.81
$2.96
P/E Ratio
$97.78
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$52.38
$12.26
52 Week High
$229.33
$16.17

Technical Indicators

Market Signals
Indicator
FIVE
RDY
Relative Strength Index (RSI) 48.74 39.52
Support Level $136.72 $13.80
Resistance Level $229.33 $14.14
Average True Range (ATR) 7.65 0.22
MACD -1.98 -0.08
Stochastic Oscillator 19.75 2.55

Price Performance

Historical Comparison
FIVE
RDY

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: